PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.13

Change

-0.10 (-1.22)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.13 (+3.34%)

USD 12.27B
QLD ProShares Ultra QQQ

+0.33 (+0.34%)

USD 7.32B
FNGU MicroSectors FANG+ Index 3X Le..

+6.98 (+1.79%)

USD 5.28B
SSO ProShares Ultra S&P500

+0.04 (+0.05%)

USD 5.17B
UPRO ProShares UltraPro S&P500

+0.01 (+0.01%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+1.61 (+1.98%)

USD 3.28B
USD ProShares Ultra Semiconductors

+3.76 (+3.37%)

USD 1.18B
YINN Direxion Daily FTSE China Bull..

+9.04 (+21.81%)

USD 1.15B
LABU Direxion Daily S&P Biotech Bul..

+0.29 (+0.23%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

-0.73 (-0.81%)

USD 0.80B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.90% 18% F 41% F
Dividend Return 1.00% 54% F 18% F
Total Return 5.91% 18% F 34% F
Trailing 12 Months  
Capital Gain 26.44% 13% F 65% D
Dividend Return 1.81% 51% F 26% F
Total Return 28.24% 12% F 61% D-
Trailing 5 Years  
Capital Gain -35.29% 26% F 13% F
Dividend Return 2.10% 34% F 6% D-
Total Return -33.20% 26% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.96% N/A N/A 23% F
Dividend Return -2.47% N/A N/A 14% F
Total Return 0.49% N/A N/A 12% F
Risk Return Profile  
Volatility (Standard Deviation) 105.69% N/A N/A 7% C-
Risk Adjusted Return -2.34% N/A N/A 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike